MedTrace Logo

Vaginal Infection Study

NCT00616330 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1443

Last updated 2012-03-05

No results posted yet for this study

Summary

This study will evaluate the efficacy and safety of a vaginal product compared with that of other vaginal products in the treatment of vaginal infections.

Conditions

  • Vulvovaginitis
  • Vaginitis

Interventions

DRUG

clindamycin phosphate/butoconazole nitrate

semi solid, single dose

DRUG

clindamycin phosphate

semi solid, single dose

DRUG

butoconazole nitrate

semi solid, single dose

Sponsors & Collaborators

  • Lumara Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Jim Joffrion · Lumara Health, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States
  • India
  • Puerto Rico
  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00616330 on ClinicalTrials.gov